Health Care: Drugs

AstraZeneca PLC (AZN: NYSE)

$25.94 0.12 | 0.46%
12/06/16 - 11:56 AM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 24.71B 26.55B 25.81B 27.97B
Cost of Sales 1.79B 2.56B 678.00M 2.88B
Gross Operating Profit 22.91B 23.99B 25.13B 25.10B
Selling, General, and Administrative Expenses 11.45B 13.32B 12.51B 10.16B
Research & Development 6.00B 5.58B 4.82B 5.24B
Operating Income before D & A (EBITDA) 5.47B 5.08B 7.79B 9.70B
Depreciation & Amortization 2.85B 3.28B 4.58B 2.52B
Interest Income 10.00M 16.00M 18.00M 0.00
Other Income - Net -570.00M -391.00M 29.00M -98.00M
Special Income / Charges 1.50B 335.00M 500.00M 970.00M
Total Income Before Interest Expenses (EBIT) 3.54B 1.76B 3.76B 8.05B
Interest Expense 469.00M 510.00M 492.00M 404.00M
Pre-Tax Income 3.07B 1.25B 3.27B 7.65B
Income Taxes 243.00M 11.00M 696.00M 1.38B
Minority Interest 1.00M 2.00M 15.00M 30.00M
Net Income From Continuing Operations 2.83B 1.24B 2.57B 6.27B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.83B 1.24B 2.57B 6.27B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.83B 1.23B 2.56B 6.24B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.33B 900.00M 2.07B 5.30B
Preferred Dividends
Net Income Available To Common 2.83B 1.24B 2.57B 6.27B
Basic EPS from Continuing Ops. 1.12 0.49 1.02 2.48
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.12 0.49 1.02 2.48
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.12 0.49 1.02 2.48
Basic Normalized Net Income/Share 0.52 0.36 0.82 2.09
EPS fr Continuing Ops. 1.12 0.49 1.02 2.47
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.12 0.49 1.02 2.47
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.12 0.49 1.02 2.47
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.52 0.36 0.82 2.09
Dividends Paid per Share 1.40 1.40 1.40 1.43

Portfolios with AZN

Latest AZN Headlines from TheStreet

More Financial News for AZN

Press Releases for AZN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter